Eventide Asset Management, LLC Dice Therapeutics, Inc. Transaction History

Eventide Asset Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $6.61 Million - $11.1 Million	-501,351 Reduced 26.79%	1,370,261 $20.8 Million
Q3 2021 Nov 15, 2021	BUY	$31.92 - $37.0 $59.7 Million - $69.2 Million	1,871,612 New	1,871,612 $59.2 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.